Business

Glenmark Pharma expects up to 14 % growth in India revenues in FY20

Glenmark Pharma expects up to 14 % growth in India revenues in FY20 Glenmark reported Rs 2514 crore revenues from India in FY 18 against Rs 2303 crore in the previous year growth of 10 percent.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts